Pharmacy News

WHO chief scientist disappointed by CureVac trial, Health News, ET HealthWorld

Geneva- The World Health Organization‘s chief scientist said on Friday that results from the CureVac COVID-19 vaccine‘s initial trial were disappointing.

German biotech firm CureVac’ vaccine proved only 47% effective in an initial trial read-out.

“It was disappointing to see the results from CureVac,” the WHO’s Soumya Swaminathan told a news conference.

(Reporting by Mike Shields and John Miller; Writing by Giles Elgood; Editing by Alison Williams)

Follow and connect with us on , Facebook, Linkedin

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button

Ad Block Detected

Welcome to Mediexpose, Please support our journalism by allowing ads. With support from readers like you, we can continue to deliver the best. You can support us free by simply allowing ads.